Related Experiment Video
Updated: Jun 3, 2025

04:44
Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
201
An Atypical Case of Rhabdomyolysis Following an Atypical Antidepressant Overdose
Raluca Ungureanu1,2, Ana-Maria Dumitriu1,2, Cristian Cobilinschi1,2
1Faculty of Medicine, "Carol-Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Journal of Clinical Medicine
|January 11, 2025
Summary
Bupropion overdose can cause severe rhabdomyolysis, a muscle breakdown condition. Early renal replacement therapy may be crucial for managing potential kidney complications, even without overt acute kidney injury (AKI).
Area of Science:
- Toxicology
- Pharmacology
- Nephrology
Background:
- Bupropion overdose is associated with seizures, cardiotoxicity, and neurotoxicity.
- Muscular and renal complications like rhabdomyolysis and acute kidney injury (AKI) can occur unexpectedly.
- Mechanisms linking bupropion overdose to rhabdomyolysis require further investigation.
Observation:
- A severe rhabdomyolysis case following a 4 g immediate-release bupropion ingestion is presented.
- The patient exhibited an atypical bupropion overdose presentation without typical neurotoxic or muscular symptoms.
- Early renal replacement therapy was initiated due to significant rhabdomyolysis and potential renal complications, despite the absence of overt AKI.
Findings:
- Bupropion overdose can lead to severe rhabdomyolysis with atypical clinical presentations.
- Individualized patient assessment is critical in managing complex drug overdoses.
- Early renal replacement therapy may be beneficial in cases of significant rhabdomyolysis and potential renal compromise, even without overt AKI.
Implications:
- Clinicians should suspect rhabdomyolysis in bupropion overdose cases.
- Consider early renal support for patients at risk of renal failure, even without overt kidney injury.
- A nuanced approach is needed for diagnosing and treating bupropion overdose in critically ill patients.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
192
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
192
Anticholinesterase Agents: Poisoning and Treatment
783
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
783
Enhanced Elimination of Poison
473
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
473
Prevention of Further Absorption of Poison
779
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
779
Desensitization and Tachyphylaxis
1.5K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.5K
Antidotes
608
Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
608

